Wolfe Research initiates Starbucks stock coverage with Peerperform rating

Starbucks reported Q1 FY2026 EPS of $0.56, missing consensus $0.59, while revenue beat at $9.9B versus $9.62B expected. Wolfe Research initiated coverage with a Peerperform rating (downgrade), citing an early-stage multi-year turnaround; the stock is up ~20% over six months and 18% YTD and trades at a P/E of 82. Guggenheim cut EPS estimates for 2026–2028 by $0.05 and raised its price target to $95 (Neutral), while Bernstein/SocGen reiterated Outperform with a $100 target and a 2028 EPS ambition of $3.35–4.00. Starbucks is accelerating store expansion in India via a 50/50 JV with Tata, prioritizing growth over near-term profitability amid widening losses in the region.

Analysis

Starbucks’ current story is less about a single-quarter inflection and more about asymmetric payoff from multi-year operational fixes (menu engineering, store productivity, loyalty monetization) versus front-loaded investment in emerging markets. If execution on unit-level margins and digital spend conversion continues, a 200–400bp operating-margin tailwind is achievable over 18–36 months as fixed-store costs are leveraged; conversely, sustained spending on growth markets can keep headline margins depressed for 2–3 years.

Competitive dynamics are shifting: premiumization and loyalty advantages favor a market leader with a dominant mobile ecosystem, while low-cost players (value breakfast at quick-service restaurants) cap price elasticity in the core U.S. market. Second-order supply effects matter — durable improvements hinge on stable green-bean costs, packaging inflation and freight; a repeat of a 20–30% coffee-price spike would materially compress margins even if comps hold.

Key catalysts and risks are calendarized: 1) upcoming quarterly prints that show sustained U.S. comp acceleration and margin recovery within 2–4 quarters; 2) India/JV disclosures around unit economics that will drive investor conviction on long-term TAM monetization over 3–5 years. Tail risks include a macro income shock compressing premium coffee frequency within 1–6 months and commodity or logistics shocks that erase operating leverage in the 6–12 month window.

Key Decisions for Investors

• Tactical long (12–18 months): Buy SBUX LEAP calls (12–18m expiries) sized for 2–4% portfolio exposure to capture multi-year margin recovery; target +30–40% upside, max loss = premium. Enter on a pullback of 6–10% or after the next quarter proves sequential margin improvement.
• Paired trade (6–12 months): Long SBUX / short MCD (equal notional) to isolate premium coffee share gains versus value breakfast exposure; target relative outperformance of 10–15% with stop if both names drop >12% on macro-led selloff (reduces idiosyncratic risk).
• Income/vol trade (3–6 months): Sell small size (25–50% of intended exposure) of out‑of‑the‑money 1–3 month puts to collect premium and create a lower effective entry, but hedge with 3–6 month protective puts at ~10–15% OTM to cap drawdown; risk limited to assignment or put spread width.
• Downside hedge (6–9 months): Buy SBUX puts or put spreads to protect existing long exposure ahead of India/JV operating updates or a macro event; cost should be sized as insurance (<=1% portfolio) given high idiosyncratic gamma around execution misses.